chr12-51807365-G-A
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 1P and 11B. PP2BP4_ModerateBP6BS1BS2
The NM_001330260.2(SCN8A):c.5879G>A(p.Arg1960Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000725 in 1,613,468 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1960L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001330260.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 13Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- cognitive impairment with or without cerebellar ataxiaInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- seizures, benign familial infantile, 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile convulsions and choreoathetosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myoclonus, familial, 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SCN8A | NM_001330260.2 | c.5879G>A | p.Arg1960Gln | missense_variant | Exon 27 of 27 | ENST00000627620.5 | NP_001317189.1 | |
| SCN8A | NM_014191.4 | c.5879G>A | p.Arg1960Gln | missense_variant | Exon 27 of 27 | ENST00000354534.11 | NP_055006.1 | |
| SCN8A | NM_001177984.3 | c.5756G>A | p.Arg1919Gln | missense_variant | Exon 26 of 26 | NP_001171455.1 | ||
| SCN8A | NM_001369788.1 | c.5756G>A | p.Arg1919Gln | missense_variant | Exon 26 of 26 | NP_001356717.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN8A | ENST00000354534.11 | c.5879G>A | p.Arg1960Gln | missense_variant | Exon 27 of 27 | 1 | NM_014191.4 | ENSP00000346534.4 | ||
| SCN8A | ENST00000627620.5 | c.5879G>A | p.Arg1960Gln | missense_variant | Exon 27 of 27 | 5 | NM_001330260.2 | ENSP00000487583.2 | ||
| SCN8A | ENST00000599343.5 | c.5912G>A | p.Arg1971Gln | missense_variant | Exon 26 of 26 | 5 | ENSP00000476447.3 | |||
| SCN8A | ENST00000355133.7 | c.5756G>A | p.Arg1919Gln | missense_variant | Exon 25 of 25 | 1 | ENSP00000347255.4 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152128Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000323 AC: 8AN: 247552 AF XY: 0.0000372 show subpopulations
GnomAD4 exome AF: 0.0000712 AC: 104AN: 1461340Hom.: 0 Cov.: 33 AF XY: 0.0000770 AC XY: 56AN XY: 726916 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74298 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
SCN8A: PP2 -
This variant is associated with the following publications: (PMID: 27875746) -
- -
- -
Inborn genetic diseases Uncertain:1
The p.R1960Q variant (also known as c.5879G>A), located in coding exon 26 of the SCN8A gene, results from a G to A substitution at nucleotide position 5879. The arginine at codon 1960 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Developmental and epileptic encephalopathy Benign:1
- -
Developmental and epileptic encephalopathy, 13 Benign:1
This variant was classified as: Benign. The following ACMG criteria were applied in classifying this variant: BS1,BS2. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at